Pipotiazine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Pipotiazine
Pipotiazine.svg
Clinical data
Trade namesPiportil
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral, IM
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard100.049.672 Edit this at Wikidata
Chemical and physical data
FormulaC24H33N3O3S2
Molar mass475.67 g/mol
3D model (JSmol)

Pipotiazine (Piportil), also known as pipothiazine, is a typical antipsychotic of the phenothiazine class[1] used in the United Kingdom and other countries for the treatment of schizophrenia.[2] Its properties are similar to those of chlorpromazine. A 2004 systematic review investigated its efficacy for people with schizophrenia:

Pipotiazine palmitate compared to oral antipsychotics for schizophrenia[3]
Summary
Although well-conducted and reported randomized trials are still needed to fully inform practice (no trial data exists reporting hospital and services outcomes, quality of life, satisfaction with care and economics) pipotiazine palmitate is a viable choice for both clinician and person with schizophrenia.[3]

See also[edit]

References[edit]

  1. ^ Bechelli, L. P.; Ruffino-Netto, A.; Hetem, G. (1983). "A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients". Brazilian Journal of Medical and Biological Research. 16 (4): 305–311. PMID 6143579.
  2. ^ International Drug Names
  3. ^ a b Dinesh, M; David, A; Quraishi, S (2004). "Depot pipotiazine palmitate and undecylenate for schizophrenia". Cochrane Database of Systematic Reviews. 3: CD001720.pub2. doi:10.1002/14651858.CD001720.pub2.